Game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
Our new, proprietary class of theranostics enable the ability to see a specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments.
Perspective Therapeutics is the only company in the world manufacturing and distributing Cesium 131 brachytherapy radioisotope seeds. These seeds were designed to treat a variety of cancers including prostate cancer, brain, head & neck, and lung.
Our focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies so our targeted medical doses are delivered directly to the tumor site. We believe radiation should spare healthy tissues and be delivered from the inside out.
July 10, 2023 Geoffrey Johnson, MD, PhD, the Chair of Nuclear Medicine at Mayo Clinic, presented first in human imaging data from Perspective's melanoma- targeted product VMTO1